预防双相 I 型心境发作复发及住院治疗:家庭心理治疗联合药物治疗与单纯药物治疗的对比

Preventing recurrence of bipolar I mood episodes and hospitalizations: family psychotherapy plus pharmacotherapy versus pharmacotherapy alone.

作者信息

Solomon David A, Keitner Gabor I, Ryan Christine E, Kelley Joan, Miller Ivan W

机构信息

Department of Psychiatry and Human Behavior, Brown University, Rhode Island Hospital, Providence, RI 02903-4970, USA.

出版信息

Bipolar Disord. 2008 Nov;10(7):798-805. doi: 10.1111/j.1399-5618.2008.00624.x.

Abstract

OBJECTIVES

This study compared the efficacy of three treatment conditions in preventing recurrence of bipolar I mood episodes and hospitalization for such episodes: individual family therapy plus pharmacotherapy, multifamily group therapy plus pharmacotherapy, and pharmacotherapy alone.

METHODS

Patients with bipolar I disorder were enrolled if they met criteria for an active mood episode and were living with or in regular contact with relatives or significant others. Subjects were randomly assigned to individual family therapy plus pharmacotherapy, multifamily group therapy plus pharmacotherapy, or pharmacotherapy alone, which were provided on an outpatient basis. Individual family therapy involved one therapist meeting with a single patient and the patient's family members, with the content of each session and number of sessions determined by the therapist and family. Multifamily group psychotherapy involved two therapists meeting together for six sessions with multiple patients and their respective family members, with the content of each session preset. All subjects were prescribed a mood stabilizer, and other medications were used as needed. Subjects were assessed monthly for up to 28 months. Following recovery from the index mood episode, subjects were assessed for recurrence of a mood episode and for hospitalization for such episodes.

RESULTS

Of a total of 92 subjects that were enrolled in the study, 53 (58%) recovered from their intake mood episode. The analyses in this report focus upon these 53 subjects, 42 (79%) of whom entered the study during an episode of mania. Of the 53 subjects who recovered from their intake mood episode, the proportion of subjects within each treatment group who suffered a recurrence by month 28 did not differ significantly between the three treatment conditions. However, only 5% of the subjects receiving adjunctive multifamily group therapy required hospitalization, compared to 31% of the subjects receiving adjunctive individual family therapy and 38% of those receiving pharmacotherapy alone, a significant difference. Time to recurrence and time to hospitalization did not differ significantly between the three treatment groups.

CONCLUSION

For patients with bipolar I disorder, adjunctive multifamily group therapy may confer significant advantages in preventing hospitalization for a mood episode.

摘要

目的

本研究比较了三种治疗方案在预防双相I型心境发作复发及因此类发作住院方面的疗效:个体家庭治疗联合药物治疗、多家庭团体治疗联合药物治疗以及单纯药物治疗。

方法

符合活动性心境发作标准且与亲属或重要他人共同生活或保持定期联系的双相I型障碍患者被纳入研究。受试者被随机分配至个体家庭治疗联合药物治疗组、多家庭团体治疗联合药物治疗组或单纯药物治疗组,均为门诊治疗。个体家庭治疗是指一名治疗师与一名患者及其家庭成员会面,每次治疗的内容和疗程次数由治疗师和家庭确定。多家庭团体心理治疗是指两名治疗师与多名患者及其各自家庭成员共同进行六次治疗,每次治疗的内容预先设定。所有受试者均服用心境稳定剂,其他药物按需使用。受试者接受长达28个月的每月评估。在首发心境发作恢复后,评估受试者心境发作的复发情况及因此类发作住院的情况。

结果

本研究共纳入92名受试者,其中53名(58%)从首发心境发作中恢复。本报告中的分析聚焦于这53名受试者,其中42名(79%)在躁狂发作期进入研究。在从首发心境发作中恢复的53名受试者中,三个治疗组中在第28个月前复发的受试者比例在三种治疗方案之间无显著差异。然而,接受辅助性多家庭团体治疗的受试者中只有5%需要住院,相比之下,接受辅助性个体家庭治疗的受试者中有31%需要住院,接受单纯药物治疗的受试者中有38%需要住院,差异有统计学意义。三个治疗组之间复发时间和住院时间无显著差异。

结论

对于双相I型障碍患者,辅助性多家庭团体治疗在预防心境发作住院方面可能具有显著优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索